Marino Scherillo Selected Research

oxidized low density lipoprotein

1/2020

[Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marino Scherillo Research Topics

Disease

9	Hemorrhage 09/2022 - 07/2012
6	Heart Failure 04/2024 - 12/2002
6	Acute Coronary Syndrome 09/2022 - 05/2007
4	Neoplasms (Cancer) 04/2024 - 09/2016
4	Stroke (Strokes) 01/2021 - 04/2013
3	Overweight 05/2017 - 09/2013
3	Hypertrophy 05/2003 - 01/2002
2	Myocardial Infarction 01/2021 - 12/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 07/2012
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2017 - 06/2016
2	Pulmonary Embolism 05/2017 - 09/2016
2	Hypercholesterolemia 05/2017 - 06/2016
2	Renal Insufficiency (Renal Failure) 05/2017 - 09/2016
2	Atherosclerotic Plaque (Atheroma) 05/2017 - 06/2016
2	Atrial Fibrillation 06/2013 - 04/2013
1	Cardiotoxicity 04/2024
1	Cardiomyopathies (Cardiomyopathy) 04/2024
1	Sarcopenia 04/2024
1	Hematoma 09/2022
1	COVID-19 01/2020
1	Unstable Angina 08/2017
1	ST Elevation Myocardial Infarction 08/2017
1	Chronic Renal Insufficiency 08/2017
1	Non-ST Elevated Myocardial Infarction 08/2017
1	Sudden Infant Death (SID) 05/2017
1	Obesity 09/2013
1	Ischemic Stroke 06/2013
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2013
1	Thromboembolism 04/2013
1	Respiratory Sounds (Crackle) 12/2012
1	Left Ventricular Dysfunction 12/2012
1	Gynecomastia 12/2012
1	Thrombosis (Thrombus) 07/2012
1	Ventricular Tachycardia 04/2009
1	Syncope (Fainting) 04/2009
1	Cardiac Arrhythmias (Arrythmia) 04/2009
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2006
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2004
1	Pathologic Constriction (Stenosis) 03/2003
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 02/2003

Drug/Important Bio-Agent (IBA)

7	AnticoagulantsIBA 12/2020 - 03/2013
3	CreatinineIBA 05/2017 - 03/2013
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2016 - 07/2012
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 09/2013
2	CholesterolIBA 05/2017 - 06/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2006 - 12/2002
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 04/2024
1	CytokinesIBA 04/2024
1	ChemokinesIBA 04/2024
1	AnthracyclinesIBA 04/2024
1	vericiguatIBA 04/2024
1	cangrelorIBA 09/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	oxidized low density lipoproteinIBA 01/2020
1	PCSK9 InhibitorsIBA 01/2020
1	Ezetimibe (Zetia)FDA Link 01/2020
1	LDL CholesterolIBA 01/2020
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 11/2018
1	Neprilysin (Neutral Endopeptidase)IBA 10/2018
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2018
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2018
1	Enalapril FDA LinkGeneric 10/2018
1	Vitamin K FDA Link 05/2017
1	Clopidogrel (Plavix)FDA Link 06/2016
1	Heparin (Liquaemin)FDA LinkGeneric 06/2016
1	Cardiovascular AgentsIBA 09/2013
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2013
1	Warfarin (Coumadin)FDA LinkGeneric 04/2013
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 03/2013
1	Spironolactone (Aldactone)FDA LinkGeneric 12/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2012
1	Eplerenone (Inspra)FDA LinkGeneric 12/2012
1	GlucocorticoidsIBA 12/2012
1	Mineralocorticoid Receptor AntagonistsIBA 12/2012
1	AndrogensIBA 12/2012
1	Glycoproteins (Glycoprotein)IBA 07/2012
1	Tirofiban (Aggrastat)FDA Link 07/2012
1	Eptifibatide (Integrilin)FDA Link 07/2012
1	Adenosine Triphosphate (ATP)IBA 04/2009
1	Valsartan (Vals)FDA Link 05/2006
1	anti-scl-70 autoantibodiesIBA 11/2004
1	Dipyridamole (Persantine)FDA LinkGeneric 03/2003

Therapy/Procedure

11	Therapeutics 12/2020 - 05/2006
2	Percutaneous Coronary Intervention 09/2022 - 01/2020
2	Myocardial Revascularization 05/2017 - 06/2016
2	Resistance Training 05/2003 - 01/2002
1	Punctures 09/2022
1	Patient Readmission 01/2019
1	Contraindications 11/2018
1	Stents 07/2012
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 04/2009
1	Critical Care (Surgical Intensive Care) 05/2007
1	Cardiac Resynchronization Therapy 01/2006
1	Endurance Training 02/2003